Efficacy and Safety of Crisaborole Ointment for Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and Safety of Crisaborole Ointment, a Novel, Nonsteroidal Phosphodiesterase 4 (PDE4) Inhibitor for the Topical Treatment of Atopic Dermatitis (AD) in Children and Adults
J Am Acad Dermatol 2016 Jul 07;[EPub Ahead of Print], AS Paller, WL Tom, MG Lebwohl, RL Blumenthal, M Boguniewicz, RS Call, LF Eichenfield, DW Forsha, WC Rees, EL Simpson, MC Spellman, LF Stein Gold, AL Zaenglein, MH Hughes, LT Zane, AA HebertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.